CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Sinopharm Group Co. Ltd. - 1099 CFD

    20.85
    0.48%
    0.20
    Low: 20.55
    High: 20.95
    Market Trading Hours* (UTC) Opens on Wednesday at 01:30

    Mon - Fri: 01:30 - 04:00 05:00 - 08:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.20
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021963 %
    Charges from full value of position ($-4.17)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021963%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.000045 %
    Charges from full value of position ($0.01)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.000045%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency HKD
    Margin 5%
    Stock exchange Hong Kong
    Commission on trade 0%

    *Information provided by Capital.com

    Sinopharm Group Co Ltd ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 20.95
    Open* 20.95
    1-Year Change* -24.23%
    Day's Range* 20.55 - 20.95
    52 wk Range 17.90-28.45
    Average Volume (10 days) 4.87M
    Average Volume (3 months) 110.23M
    Market Cap 60.42B
    P/E Ratio 6.22
    Shares Outstanding 3.12B
    Revenue 643.01B
    EPS 3.11
    Dividend (Yield %) 4.64876
    Beta 0.75
    Next Earnings Date Mar 22, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 23, 2024 20.80 0.25 1.22% 20.55 21.00 20.55
    Apr 22, 2024 20.95 1.10 5.54% 19.85 21.10 19.85
    Apr 19, 2024 19.85 0.30 1.53% 19.55 19.95 19.00
    Apr 18, 2024 19.70 -0.10 -0.51% 19.80 20.10 19.65
    Apr 17, 2024 19.80 0.40 2.06% 19.40 19.90 19.20
    Apr 16, 2024 19.50 0.05 0.26% 19.45 19.85 19.35
    Apr 15, 2024 19.65 0.35 1.81% 19.30 19.80 19.20
    Apr 12, 2024 19.40 -0.25 -1.27% 19.65 19.70 19.15
    Apr 11, 2024 19.80 0.45 2.33% 19.35 19.85 19.25
    Apr 10, 2024 19.75 -0.20 -1.00% 19.95 20.05 19.70
    Apr 9, 2024 19.95 0.15 0.76% 19.80 20.15 19.60
    Apr 8, 2024 19.70 -0.10 -0.51% 19.80 20.10 19.45
    Apr 5, 2024 19.90 -0.50 -2.45% 20.40 20.40 19.60
    Apr 3, 2024 20.45 0.20 0.99% 20.25 20.60 20.20
    Apr 2, 2024 20.20 -0.15 -0.74% 20.35 21.00 20.00
    Mar 28, 2024 19.95 -0.40 -1.97% 20.35 20.35 19.75
    Mar 27, 2024 20.40 0.35 1.75% 20.05 20.60 20.05
    Mar 26, 2024 19.95 -0.55 -2.68% 20.50 20.55 19.70
    Mar 25, 2024 20.25 -0.15 -0.74% 20.40 20.75 20.20
    Mar 22, 2024 20.60 0.00 0.00% 20.60 20.75 20.15

    Sinopharm Group Co. Ltd. Events

    Time (UTC) Country Event
    Friday, April 26, 2024

    Time (UTC)

    10:59

    Country

    CN

    Event

    Q1 2024 Sinopharm Group Co Ltd Earnings Release
    Q1 2024 Sinopharm Group Co Ltd Earnings Release

    Forecast

    -

    Previous

    -
    Friday, June 14, 2024

    Time (UTC)

    01:00

    Country

    CN

    Event

    Sinopharm Group Co Ltd Annual Shareholders Meeting
    Sinopharm Group Co Ltd Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, June 17, 2024

    Time (UTC)

    12:00

    Country

    CN

    Event

    SINOPHARM GROUP CO LTD
    SINOPHARM GROUP CO LTD

    Forecast

    -

    Previous

    -
    Tuesday, August 6, 2024

    Time (UTC)

    08:42

    Country

    CN

    Event

    Half Year 2024 Sinopharm Group Co Ltd Earnings Release
    Half Year 2024 Sinopharm Group Co Ltd Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 552148 521051 456415 425273 344526
    Revenue 552148 521051 456415 425273 344526
    Cost of Revenue, Total 504714 477001 416091 387741 313298
    Gross Profit 47434.1 44050.6 40323.3 37531.3 31228.1
    Total Operating Expense 531605 501949 438788 409250 329129
    Selling/General/Admin. Expenses, Total 23790.5 22101.6 20328.8 18472.1 14761.6
    Unusual Expense (Income) 61.683 609.395 133.753 113.698 356.903
    Other Operating Expenses, Total -676.163 -589.193 -652.002 -441.164 -373.85
    Operating Income 20542.8 19102.6 17626.2 16023 15397.2
    Interest Income (Expense), Net Non-Operating -1886.65 -2071.41 -1780.62 -2030.51 -2743.49
    Gain (Loss) on Sale of Assets 39.482 64.387 39.384 4.81 15.751
    Other, Net -131.801 -92.401 -286.893 -237.537 -461.561
    Net Income Before Taxes 18563.8 17003.2 15598.1 13759.8 12207.9
    Net Income After Taxes 14345.4 13064.8 12097.3 10620.1 9404.48
    Minority Interest -5819.79 -5306.13 -4910.01 -4367.54 -3568.64
    Net Income Before Extra. Items 8525.66 7758.65 7187.28 6252.54 5835.84
    Net Income 8525.66 7758.65 7187.28 6252.54 5835.84
    Income Available to Common Excl. Extra. Items 8525.66 7758.65 7187.2 6251.35 5835.84
    Income Available to Common Incl. Extra. Items 8525.66 7758.65 7187.2 6251.35 5835.84
    Diluted Net Income 8525.66 7758.65 7187.2 6251.35 5833.55
    Diluted Weighted Average Shares 3120.66 3120.66 3111.29 2969.65 2971.66
    Diluted EPS Excluding Extraordinary Items 2.73201 2.48622 2.31004 2.10508 1.96306
    Dividends per Share - Common Stock Primary Issue 0.79486 0.71052 0.70652 0.58283 0.58928
    Diluted Normalized EPS 2.7375 2.62042 2.33356 2.13338 2.0515
    Depreciation / Amortization 1779.04 1695.37 1612.97 1413.44 1086.2
    Dilution Adjustment -2.295
    Interest Expense (Income) - Net Operating 1936.17 1130.82 1273.56 1950.18
    Total Adjustments to Net Income -0.074 -1.182
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 300950 290676 261472 271931 249120
    Revenue 300950 290676 261472 271931 249120
    Cost of Revenue, Total 277680 264899 239814 248468 228533
    Gross Profit 23270.7 25776.6 21657.5 23463.4 20587.2
    Total Operating Expense 291365 279197 252407 261612 240336
    Selling/General/Admin. Expenses, Total 13691.1 13144.9 12424.7 12039.4 11757.6
    Interest Expense (Income) - Net Operating 250.389 1526.66 409.515 829.943 300.878
    Unusual Expense (Income) -3.637 69.104 -7.421 621.096 -11.701
    Other Operating Expenses, Total -252.209 -442.48 -233.683 -345.899 -243.294
    Operating Income 9585.02 11478.4 9064.43 10318.8 8783.73
    Interest Income (Expense), Net Non-Operating -736.54 -898.501 -988.144 -1037.71 -1033.7
    Gain (Loss) on Sale of Assets 140.156 26.862 12.62 20.34 44.047
    Other, Net -122.605 -46.567 -85.234 -15.267 -77.134
    Net Income Before Taxes 8866.03 10560.1 8003.67 9286.21 7716.95
    Net Income After Taxes 6893.23 8116.82 6228.62 7036.24 6028.53
    Minority Interest -2788.79 -3284.91 -2534.87 -2860.44 -2445.69
    Net Income Before Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
    Net Income 4104.44 4831.91 3693.74 4175.81 3582.84
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
    Income Available to Common Incl. Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
    Diluted Net Income 4104.44 4831.91 3693.74 4175.81 3582.84
    Diluted Weighted Average Shares 3116.82 3120.66 3120.66 3120.66 3120.66
    Diluted EPS Excluding Extraordinary Items 1.31687 1.54836 1.18364 1.33812 1.1481
    Dividends per Share - Common Stock Primary Issue 0 0.79486 0 0.71052 0
    Diluted Normalized EPS 1.281 1.55877 1.17865 1.48398 1.13415
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 319406 290922 267610 230000 204655
    Cash and Short Term Investments 55222.1 43541.2 50217.4 39192.1 40340.2
    Cash 55221.6 43529.4 50178.3 39192 40299
    Short Term Investments 0.498 11.749 39.141 0.156 41.199
    Total Receivables, Net 175733 176273 149448 126563 110364
    Accounts Receivable - Trade, Net 153283 159409 134404 109497 96609.7
    Total Inventory 60925.8 51499.6 47085.4 42594.4 35388.9
    Prepaid Expenses 12288.8 7101.88 8176.93 8794.3 9689.56
    Other Current Assets, Total 15236.8 12506.1 12681.8 12855.6 8872.24
    Total Assets 364775 335412 311237 269888 235771
    Property/Plant/Equipment, Total - Net 19647.2 19407.8 18895.8 18063 11025.1
    Property/Plant/Equipment, Total - Gross 34492.5 28241.1 26299.4 24268.1 16207.7
    Accumulated Depreciation, Total -14845.3 -8833.35 -7403.56 -6205.03 -5182.61
    Goodwill, Net 7155.58 7199.01 7287.39 5664.07 4899.38
    Intangibles, Net 3015.34 3192.72 3441.91 3324.78 2577.35
    Long Term Investments 10378.8 9772.64 9106.92 8519.99 7648.67
    Note Receivable - Long Term 5.862 11.816 33.504 18.288 9.665
    Other Long Term Assets, Total 5166.01 4906.24 4861.16 4298.52 4956.3
    Total Current Liabilities 234963 219307 203977 178425 160074
    Accounts Payable 137085 128431 112632 100334 83682.9
    Accrued Expenses 9571.47 8354.29 7760.01 6355.49 5309.51
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 54633.2 56699.7 56365.1 43668.9 50085.2
    Other Current Liabilities, Total 33673.2 25821.3 27219.6 28066.5 20996.7
    Total Liabilities 296707 273526 254878 222466 192949
    Total Long Term Debt 14957 11668.5 12161.7 11470.3 5019.1
    Long Term Debt 11750.4 8418.68 8918.73 8372.85 4951.17
    Capital Lease Obligations 3206.56 3249.87 3243.01 3097.49 67.934
    Deferred Income Tax 936.744 1022.79 1111.74 1099.11 864.906
    Minority Interest 42000.6 37767.9 33588.5 29517.2 25453.9
    Other Liabilities, Total 3849.25 3760.5 4038.81 1954.93 1536.92
    Total Equity 68068.6 61886 56358.8 47422.1 42821.8
    Common Stock 3120.66 3120.66 3120.66 2971.66 2971.66
    Additional Paid-In Capital 24641.5 24641.5 24641.5 21223.1 21223.1
    Retained Earnings (Accumulated Deficit) 40289.2 34103.4 28574 23211.7 18615
    Unrealized Gain (Loss) 17.217 20.485 22.655 15.649 12.067
    Total Liabilities & Shareholders’ Equity 364775 335412 311237 269888 235771
    Total Common Shares Outstanding 3120.66 3120.66 3120.66 2971.66 2971.66
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 372155 319406 325263 290922 299953
    Cash and Short Term Investments 34377.5 55222.1 32146.4 43541.2 34359.9
    Cash 34377.1 55221.6 32146 43529.4 34359.7
    Short Term Investments 0.422 0.498 0.347 11.749 0.169
    Total Receivables, Net 241477 171204 211754 172576 191112
    Accounts Receivable - Trade, Net 229825 153952 201222 159885 182457
    Total Inventory 66922.9 60925.8 56992.1 51499.6 50819.7
    Prepaid Expenses 18721.9 20016.4 15532.5 13611.3 15489.2
    Other Current Assets, Total 10655.2 12038 8838.3 9694.53 8172.28
    Total Assets 417692 364775 370180 335412 344331
    Property/Plant/Equipment, Total - Net 19655.4 19647.2 19380.7 19407.8 18937.2
    Intangibles, Net 10138.7 10170.9 10291.7 10391.7 11006.6
    Long Term Investments 10606.6 10378.8 10203 9772.64 9354.3
    Note Receivable - Long Term 2.773 5.862 9.887 11.816 28.49
    Other Long Term Assets, Total 5133.11 5166.01 5031.51 4906.24 5051.63
    Total Current Liabilities 281307 234963 248980 219307 232316
    Accounts Payable 156639 137085 131277 128431 121330
    Accrued Expenses 35160.7 30889.7 29091.9 26229.8 27755
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 76300.4 54633.2 78161.2 56699.7 73183.7
    Other Current Liabilities, Total 13206.3 12355 10450.2 7945.87 10048
    Total Liabilities 348087 296707 306939 273526 286542
    Total Long Term Debt 18534 14957 13742.5 11668.5 13603.6
    Long Term Debt 15225.8 11750.4 10377.7 8418.68 10321
    Capital Lease Obligations 3308.25 3206.56 3364.82 3249.87 3282.6
    Deferred Income Tax 877.788 936.744 1002.66 1022.79 1073.05
    Minority Interest 43506.1 42000.6 39507.1 37767.9 35387.9
    Other Liabilities, Total 3862.44 3849.25 3706.84 3760.5 4161.29
    Total Equity 69604.5 68068.6 63240.9 61886 57788.8
    Common Stock 3120.66 3120.66 3120.66 3120.66 3120.66
    Retained Earnings (Accumulated Deficit) 66483.9 64947.9 60120.3 58765.4 54668.2
    Total Liabilities & Shareholders’ Equity 417692 364775 370180 335412 344331
    Total Common Shares Outstanding 3120.66 3120.66 3120.66 3120.66 3120.66
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 18563.8 17003.2 15598.1 13759.8 12207.9
    Cash From Operating Activities 20963.8 9308.08 11154.6 18777.1 3653.74
    Cash From Operating Activities 3774.36 3540.39 3207.08 2655.68 1091.22
    Amortization 390.661 381.673 390.034 458.396 303.458
    Non-Cash Items 4707.74 4558.32 4334.84 4880.49 3483.94
    Cash Taxes Paid 4399.09 4074.12 3655.48 3441.27 2767.49
    Cash Interest Paid 4777.93 4575.12 4643.62 5180.18 4052.38
    Changes in Working Capital -6472.79 -16175.5 -12375.4 -2977.28 -13432.8
    Cash From Investing Activities -3589.62 -1266.96 -2202.76 -6795.97 -5907.62
    Capital Expenditures -2417.53 -2255.64 -2087.32 -2548.83 -3404.12
    Other Investing Cash Flow Items, Total -1172.09 988.68 -115.434 -4247.13 -2503.5
    Cash From Financing Activities -5693.48 -14693 2025.85 -13084.6 10318.5
    Financing Cash Flow Items -6273.77 -5997.19 -6145.98 -5913.01 -2390.2
    Total Cash Dividends Paid -2340.49 -2153.25 -1865.12 -1753.28 -1577.03
    Issuance (Retirement) of Debt, Net 2920.78 -6542.56 6436.55 -5468.43 14282.9
    Foreign Exchange Effects 11.512 3.047 8.593 -3.582 -6.445
    Net Change in Cash 11692.2 -6648.84 10986.3 -1107.02 8058.19
    Issuance (Retirement) of Stock, Net 0 3600.4 50.152 2.833
    Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
    Cash From Operating Activities 20963.8 -34293.4 9308.08 -27768.4 11154.6
    Cash Taxes Paid 4399.09 2391.25 4074.12 2141.95 3655.48
    Cash Interest Paid 4777.93 1847.91 4575.12 1960.69 4643.62
    Changes in Working Capital -6472.79 -46872.9 -16175.5 -39610.7 -12375.4
    Cash From Investing Activities -3589.62 391.025 -1266.96 88.304 -2202.76
    Capital Expenditures -2417.53 -922.7 -2255.64 -852.924 -2087.32
    Other Investing Cash Flow Items, Total -1172.09 1313.72 988.68 941.228 -115.434
    Cash From Financing Activities -5693.48 22513.6 -14693 11860.4 2025.85
    Financing Cash Flow Items -6273.77 -2524.05 -5997.19 -2852.99 -6145.98
    Total Cash Dividends Paid -2340.49 -2153.25 0 -1865.12
    Issuance (Retirement) of Stock, Net 0 0 3600.4
    Issuance (Retirement) of Debt, Net 2920.78 25037.6 -6542.56 14713.4 6436.55
    Foreign Exchange Effects 11.512 5.419 3.047 1.097 8.593
    Net Change in Cash 11692.2 -11383.4 -6648.84 -15818.5 10986.3
    Net income/Starting Line 18563.8 8003.67 17003.2 7716.95 15598.1
    Cash From Operating Activities 3774.36 1822.07 3540.39 1708.94 3207.08
    Amortization 390.661 178.615 381.673 172.975 390.034
    Non-Cash Items 4707.74 2575.15 4558.32 2243.5 4334.84

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Sinopharm Company profile

    About SINOPHARM HOLDING CO LTD

    Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, SINOPHARM HOLDING CO LTD revenues increased 14% to RMB521.05B. Net income applicable to common stockholders increased 8% to RMB7.76B. Revenues reflect Retail Sales - Total increase of 20% to RMB28.57B. Net income was partially offset by Impairment of Intangibles increase from RMB265M to RMB606.9M (expense), Bank and other borrowings increase of 10% to RMB2.87B (expense).

    Industry: Pharmaceuticals Wholesale

    黄浦区龙华东路385号12层
    SHANGHAI
    SHANGHAI 200023
    CN

    Income Statement

    • Annual
    • Quarterly

    News

    We’re partnering with Newsquawk

    Filter out the noise and focus on the news that matters.

    08:32, 23 April 2024

    US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

    The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

    15:56, 22 April 2024

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    People also watch

    BTC/USD

    66,184.80 Price
    -0.840% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    ETH/USD

    3,189.64 Price
    -0.340% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    US100

    17,284.20 Price
    +0.360% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Gold

    2,311.15 Price
    -0.720% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading